Emergent Paradigms of Thrombosis and Cancer (Part II): More on Thrombosis and Cancer

Hau C. Kwaan; Paul F. Lindholm

doi:10.1055/s-0039-1694764

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2019; 45(06): 557-558
DOI: 10.1055/s-0039-1694764

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Emergent Paradigms of Thrombosis and Cancer (Part II): More on Thrombosis and Cancer

Authors

Hau C. Kwaan

¹Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
Paul F. Lindholm

²Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois

Abstract

Full Text

References

References
1 Kwaan HC, Lindholm PF. Emergent paradigms of thrombosis and cancer (part I): the yin yang relationship between thrombosis and cancer. Semin Thromb Hemost 2019; 45 (04) 319-320
2 Sharma BK, Flick MJ, Palumbo JS. Cancer-associated thrombosis: a two-way street. Semin Thromb Hemost 2019; 45 (06) 559-568
3 Mege D, Aubert M, Lacroix R, Dignat-George F, Panicot-Dubois L, Dubois C. Involvement of platelets in cancers. Semin Thromb Hemost 2019; 45 (06) 569-575
4 Dvorak HF. Tumors: wounds that do not heal—a historical perspective with a focus of the fundamental roles of increased vascular permeability and clotting. Semin Thromb Hemost 2019; 45 (06) 576-592
5 Lacroix R, Vallier L, Bonifay A. , et al. Microvesicles and cancer associated thrombosis. Semin Thromb Hemost 2019; 45 (06) 593-603
6 Arachchillage DRJ, Laffan M. Pathogenesis and management of thrombotic disease in myeloproliferative neoplasms. Semin Thromb Hemost 2019; 45 (06) 604-611
7 Kwaan HC, Weiss I, Tallman MS. The role of abnormal hemostasis and fibrinolysis in morbidity and mortality of acute promyelocytic leukemia. Semin Thromb Hemost 2019; 45 (06) 612-621
8 Nadir Y. Decrease in tumor growth and angiogenesis mediated by coagulation inhibition. Semin Thromb Hemost 2019; 45 (06) 622-628
9 Park DY, Khorana AA. Risks and benefits of anticoagulation in cancer and non-cancer patients. Semin Thromb Hemost 2019; 45 (06) 629-637
10 Suryanarayan D, Lee AYY, Wu C. Direct oral anticoagulants in cancer patients. Semin Thromb Hemost 2019; 45 (06) 638-647
11 Ramsey G, Lindholm PF. Thrombosis risk in cancer patients receiving red cell transfusions. Semin Thromb Hemost 2019; 45 (06) 648-656